By TCOYD on May 2, 2022 / A Dose of Dr. E, CGM, Eversense, Video / 35 Comments The Eversense E3 implantable CGM is a unique continuous glucose monitoring system, and it was recently approved for 6-month wear time, the longest of any CGM on the market. Drs. E+P share more about the features and highlights. Previous Post Diabetes and Marijuana: What's All the High - Er, Hype - About? Next Post The World’s Smallest CGM Gets FDA Approval, and Bigger Isn’t Always Better!